Decitabine and venetoclax for IDH1/2-mutated acute myeloid leukemia.
Sangeetha VenugopalAbhishek MaitiCourtney D D DiNardoSanam LoghaviNaval G DaverTapan Mahendra KadiaCaitlin R RauschYesid AlvaradoMaro Ohanian DOKoiji SasakiNicholas James ShortKoichi TakahashiMusa YlimazFarhad RavandiHagop M KantarjianMarina Y KonoplevaPublished in: American journal of hematology (2021)